China Universal Asset Management Co. Ltd. purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 32,315 shares of the company's stock, valued at approximately $1,091,000.
Several other institutional investors and hedge funds have also recently modified their holdings of TEM. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI in the third quarter valued at approximately $30,000. Geode Capital Management LLC increased its holdings in Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock worth $7,537,000 after purchasing an additional 539 shares during the last quarter. FNY Investment Advisers LLC bought a new position in Tempus AI during the 4th quarter worth approximately $67,000. Vestor Capital LLC acquired a new stake in Tempus AI during the third quarter worth about $153,000. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Tempus AI by 10.2% during the third quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company's stock valued at $1,686,000 after acquiring an additional 2,765 shares during the period. Hedge funds and other institutional investors own 24.22% of the company's stock.
Analyst Ratings Changes
Several research firms have commented on TEM. Piper Sandler reissued a "neutral" rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Needham & Company LLC reiterated a "buy" rating and issued a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Stifel Nicolaus downgraded Tempus AI from a "buy" rating to a "hold" rating and upped their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Bank of America increased their price target on Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a research note on Friday, December 13th. Finally, TD Cowen reissued a "buy" rating and set a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a report on Wednesday. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $58.55.
Read Our Latest Stock Analysis on TEM
Tempus AI Trading Up 12.8 %
Shares of NASDAQ TEM traded up $7.92 during mid-day trading on Wednesday, hitting $69.77. 19,457,225 shares of the stock were exchanged, compared to its average volume of 11,171,247. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The stock's fifty day simple moving average is $44.20 and its two-hundred day simple moving average is $48.58.
Insider Buying and Selling at Tempus AI
In other news, EVP Andrew Polovin sold 51,504 shares of the company's stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.39, for a total value of $2,183,254.56. Following the completion of the transaction, the executive vice president now directly owns 246,085 shares in the company, valued at approximately $10,431,543.15. This represents a 17.31 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the sale, the insider now directly owns 16,164,449 shares of the company's stock, valued at approximately $694,263,084.55. This trade represents a 2.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,037,702 shares of company stock worth $89,449,651 over the last ninety days.
Tempus AI Company Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
